Last modification: 2011/08/22

Autor(en) Titel Quelle Links
Ifversen M, Meisel R, Sedlacek P, Kalwak K, Sisinni L, Hutt D, Lehrnbecher T, Balduzzi A, Diesch T, Jarisch A, Güngör T, Stein J, Yaniv I, Bonig H, Kuhlen M, Ansari M, Nava T, Dalle JH, Diaz-de-Heredia C, Trigoso E, Falkenberg U, Hartmann M, Deiana M, Canesi M, Broggi C, Bertaina A, Gibson B, Krivan G, Vettenranta K, Matic T, Buechner J, Lawitschka A, Peters C, Yesilipek A, Yalçin K, Lucchini G, Bakhtiar S, Turkiewicz D, Niinimäki R, Wachowiak J, Cesaro S, Dalissier A, Corbacioglu S, Willasch AM, Bader P Supportive Care During Pediatric Hematopoietic Stem Cell Transplantation: Prevention of Infections. A Report From Workshops on Supportive Care of the Paediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT). Frontiers in pediatrics 2021, 9: 705179    
Ilmer M, Garnier A, Vykoukal J, Alt E, von Schweinitz D, Kappler R, Berger M Targeting the Neurokinin-1 Receptor Compromises Canonical Wnt Signaling in Hepatoblastoma. Molecular cancer therapeutics 2015, 14: 2712    
Imamura J, Bartram C, Berthold F, Harms D, Nakamura H, Koeffler H Mutation of the p53 gene in neuroblastoma and its relationship with N-myc amplification. Cancer Res 1993, 53: 4053    
Imashuku S, Kuriyama K, Teramura T, Ishii E, Kinugawa N, Kato M, Sako M, Hibi S Requirement for etoposide in the treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001, 19: 2665    
Imashuku S Clinical features and treatment strategies of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Critical reviews in oncology/hematology 2002, 44: 259    
Imashuku S, Kuriyama K, Sakai R, Nakao Y, Masuda S, Yasuda N, Kawano F, Yakushijin K, Miyagawa A, Nakao T, Teramura T, Tabata Y, Morimoto A, Hibi S Treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis (EBV-HLH) in young adults: a report from the HLH study center. Medical and pediatric oncology 2003, 41: 103    
Imai K, Morio T, Zhu Y, Jin Y, Itoh S, Kajiwara M, Yata J, Mizutani S, Ochs HD, Nonoyama S Clinical course of patients with WASP gene mutations. Blood 2004 Jan 15; 103: 456    
Imbach P, Kühne T, Gaedicke G Idiopathische thrombozytopenische Purpura. In: Gadner, H, Gaedicke, G, Niemeyer, C, Ritter, J (Hrsg.): Pädiatrische Hämatologie und Onkologie 2006, S. 357 ff.    
Imbach P, Kühne T, Müller D, Berchtold W, Zimmerman S, Elalfy M, Buchanan GR Childhood ITP: 12 months follow-up data from the prospective registry I of the Intercontinental Childhood ITP Study Group (ICIS). Pediatric blood & cancer 2006, 46: 351    
Imhof SM, Moll AC, Hofman P, Mourits MP, Schipper J, Tan KE Second primary tumours in hereditary- and nonhereditary retinoblastoma patients treated with megavoltage external beam irradiation. Documenta ophthalmologica. Advances in ophthalmology 1997, 93: 337    
Inati-Khoriati, A Die Sichelzellkrankheit: Eine Informationsbroschüre für Eltern, Patienten und die Allgemeinheit.    
Inaba H, Rubnitz JE, Coustan-Smith E, Li L, Furmanski BD, Mascara GP, Heym KM, Christensen R, Onciu M, Shurtleff SA, Pounds SB, Pui CH, Ribeiro RC, Campana D, Baker SD Phase I pharmacokinetic and pharmacodynamic study of the multikinase inhibitor sorafenib in combination with clofarabine and cytarabine in pediatric relapsed/refractory leukemia. J Clin Oncol 2011 29: 3293    
Inusa B, Casale M, Booth C, Lucas S Subarachnoid haemorrhage and cerebral vasculopathy in a child with sickle cell anaemia. BMJ case reports 2014,    
Iolascon A, Russo R, Delaunay J Congenital dyserythropoietic anemias. Current opinion in hematology 2011, 18: 146    
De Ioris MA, Fidani P, Munier FL, Serra A, Ilari I, Popovic MB, Natali G, Secco DE, Cozza R Successful treatment of trilateral retinoblastoma with conventional and high-dose chemotherapy plus radiotherapy: a case report. Journal of pediatric hematology/oncology 2010, 32:e343    
Irtan S, Van Tinteren H, Graf N, van den Heuvel-Eibrink MM, Heij H, Bergeron C, de Camargo B, Acha T, Spreafico F, Vujanic G, Powis M, Okoye B, Wilde J, Godzinski J, Pritchard-Jones K Evaluation of needle biopsy as a potential risk factor for local recurrence of Wilms tumour in the SIOP WT 2001 trial. European journal of cancer 2019, 116: 13    
Irving J, Matheson E, Minto L, Blair H, Case M, Halsey C, Swidenbank I, Ponthan F, Kirschner-Schwabe R, Groeneveld-Krentz S, Hof J, Allan J, Harrison C, Vormoor J, von Stackelberg A, Eckert C Ras pathway mutations are prevalent in relapsed childhood acute lymphoblastic leukemia and confer sensitivity to MEK inhibition. Blood 2014, 124: 3420    
Isakoff MS, Bielack SS, Meltzer P, Gorlick R Osteosarcoma: Current Treatment and a Collaborative Pathway to Success. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2015 Sep 20; 33: 3029    
Iversen P, Turczynowicz S, Lewis J, Hasle H, Niemeyer C, Schmiegelow K, Bastiras S, Biondi A, Hughes T, Lopez A A second generation GM-CSF analogue that prevents dissemination and includes remission of human juvenile myelomonocytic leukemia in engrafted immunodeficient mice. Blood 1997, 90: 4910    
Izraeli S, Janssen J, Haas O, Harbott J, Brok-Simoni F, Walther J, Kovar H, Henn T, Ludwig W, Reiter A, Detection and clinical relevance of genetic abnormalities in pediatric acute lymphoblastic leukemia. Leukemia 1993, 7: 671    
20 items found

The literature database is sorted by the first author's last name - please choose from the alphabet. It comprises the references that were reported by the trial co-ordinating centres and those which are referenced in this information service, for example by the patient information texts.